OTHER · Unmapped registry intervention
Biomarkers
Find medicine records ·
Find other trials using this name
Clinical trial
Novel Molecular Targets for Ductal Carcinoma In Situ (DCIS)
NCT03148015
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedNovel Molecular Targets for Ductal Carcinoma In Situ (DCIS)
Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Breast Cancerverified · MONDO: breast cancer
Interventions
BiomarkersOTHER
Sponsors & collaborators
Sentara Norfolk General Hospitallead sponsor
George Mason Universitycollaborator
Dorothy G. Hoefer Foundationcollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03148015 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.